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Supplementary figure legends 
 
Supplementary Figure S1. Celecoxib induces MAGI1 in colorectal carcinoma 
cells. (a) The colorectal carcinoma-derived cell lines HCT116, SW620, DLD1, T84 
and HT29 were treated with 50 µM celecoxib for 4 days and then analyzed for 
MAGI1 by Western blotting. Celecoxib treatment induced MAGI1 expression in all 
cell lines except in DLD1 cells. (b) The same cell lines were analyzed by Western 
blotting for COX-2 expression. The DLD1 cell line does express very low level os 
COX-2. Actin immunoblotting demonstrates equivalent protein loading across 
different lanes. (c) The same cell lines were analyzed by real time RT-PCR for COX-
2 expression to confirm low level of COX-2 expression in DLD1 cells. Numbers on 
top of the columns indicate levels of COX-2 mRNA relative to HT29. (d) SW480 (S) 
and HCT16 cells (H) were analyzed for E-prostane receptor (EP) 1-4 expression by 
RT-PCR. SW480 and HCT16 cells express mostly EP4. (e). Treatment of SW480 
cells for 24 hours with the stabilized PGE2 analogue 16, 16 dimethyl PGE2 (dm 
PGE2) decreases MAGI1 mRNA levels (mean values ± S.D.). *p<0.001 to untreated.  
 
 
Supplementary Figure S2. Celecoxib suppresses SW480 tumor growth. (a) One 
million SW480 cells were injected s.c into Swiss nu/nu mice. At day 7 mice were 
randomized and one group was treated with celecoxib mixed with a powdered rodent 
chow diet at a concentration of 1000 ppm. Tumors were measured at the indicated 
time points. Celebrex treatment slows tumor growth. Results represent mean values 
± S.D. *p<0.001 to control. (N=7). (b) Western blotting analysis of MAGI1 expression 
in tumors derived from subcutaneously implanted SW480 cells. Here shown are 
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control (mice 1-4) and mice treated with celecoxib (mice 5-8). Tumors growing in 
celebrex-treated mice have increased levels of MAGI1 protein. Actin immunoblotting 
demonstrates equivalent protein loading across different lanes. 
 
 
Supplementary Figure S3. MAGI1 overexpression and silencing in SW480 and 
HCT116 cells. (a) Western blotting analysis of MAGI1 expression in wild type 
SW480 (WT), SW480 overexpressing MAGI1 (MAGI1) and SW480 expressing 3 
different MAGI1 shRNA (sh1, sh2, sh3). Clone sh3, was used for further analyses. 
(b) Western blotting analysis of MAGI1 expression in wild type HCT116 (WT) and 
HCT116 expressing 3 different MAGI1 shRNA (sh1, sh2, sh3). Clone 2 was used for 
further analyses. NS, cells expressing non-silencing sh constructs. (c) Relative levels 
of MAGI1 overexpressed in SW480 cells compared to MAGI1 levels induced by 4- 
day culture in the presence of celecoxib. MAGI1 cDNA expression gives rise to a 
protein smaller than endogenous MAGI1, consistent with published results (Ide et al., 
1999). Actin is detected to demonstrate equal loading.  
 
 
Supplementary Figure S4. Effect of MAGI1 on HCT116 cell migration and 
invasion. (a) MAGI1 overexpression reduces HCT116 cell migration through 
uncoated Transwell filters (left panel) and invasion through Matrigel-coated 
(0.5mg/ml) Transwell filters (right panel). Results represent the average number of 
cells per field±S.D. counted on the lower side of the insert membrane. p<0.001 to 
WT. (N=3). (b) MAGI1 overexpression slightly reduces SW480 cell proliferation 
under standard culture conditions, while MAGI silencing slightly promotes it. *p<0.02 
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to WT. WT, wild type cells; MAGI1, MAGI1 overexpressing cells; shMAGI1, MAGI1 
silenced cells, shNS, non-silenced cells.  
 
 
Supplementary Figure S5. Chracterization of SW480 integrin-mediated 
adhesion of matrix proteins (a) Effect of MAG1 levels on cell surface integrin 
expression. To determine integrin expression, wild type, MAGI1 overexpressing and 
MAGI1 silenced SW480 cells were stained by indirect immunofluorescence with anti-
integrin antibodies specific for the subunits α4, α5, α6, β1 and the integrin complex 
αVβ3, and analyzed by flow cytometry. Modulation of MAGI1 had no impact on cell 
surface in integrin expression. (b) Antibody blocking of integrin-mediated adhesion. 
SW480 cells were plated on PLL (as integrin-independent adhesion control), on 
laminin, fibronectin and collagen I in the absence or presence of anti-integrin 
blocking mAbs as indicated. Results are given and mean ± S.D. of triplicate 
determinations and are shown as O.D. of crystal violet-stained wells. MAGI1-
enhanced cell adhesion was fully dependent on integrin. GoH3, anti-α6; Gl9, anti-α2; 
Lia1/2, anti-β1; SAM1, anti-α5; LM609αβ. WT, wild type; MAGI1, MAGI1 
overexpressing; shMAGI1, MAGI1 silenced. 
 
 
Supplementary Figure S6. MAGI1 overexpression inhibits Wnt signaling in 
HCT116 cells. (a) Measurement of TCF/LEF transcriptional activity in HCT116 cells 
using the TOP/FOP Flash activity assay. Cells were transfected with Flash plasmids 
expressing either the β-catenin responsive elements (TOP) or and control sequence 
(FOP). Activities were normalized to co-transfected Renilla luciferase and expressed 
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here as the TOP/FOP ratio. MAGI1 silencing (shMAGI) enhanced TOPFlash activity, 
while MAGI1 overexpression (MAGI) decreased it. WT, HCT116 wild type cells, 
shNS, HCT116 cells expressing a non-silencing shRNA. *p<0.001 to WT. (N=3). (b) 
Measurement of Axin2 mRNA levels by real-time RT-PCR in the same cells of panel 
A. MAGI1 silencing (shMAGI) enhanced Axin2 level, while MAGI1 overexpression 
(MAGI) decreased it. Results represent mean values ± S.D. and are shown as the 
fold difference relative to Axin2 level in SW480 WT cells normalized to GAPDH 
levels. * p<0.001 to WT. (N=3). 
 
 
Supplementary Figure S7. Microvascular densitiy in clelcoxib treated tumors, 
and MAGI1 effect on orthotopic SW480 tumor growth. (a) Microvascular density 
(MVD) in celebrex-treated SW480 tumors and untreated tumors was determined by 
CD31 staining and vessel count. Celebrex significantly reduces MVD, * p<0.001 to 
corresponding untreated tumors. (b) Luciferase-expressing wild type, MAGI1 
overexpressing and MAGI1 silenced SW480 cells (1 x 106) were injected 
orthotopically into the cecum of NSG mice and tumor growth was monitored non-
invasively by detecting in vivo luciferase activity. Results represent mean photon 
values within the tumor region of interest. Data are the same as those shown if 
Figure 5d, except that results are given in a logarithmic scale. *p<0.05, **p<0.001 to 
WT. (N=4). WT, wild type; MAGI1, MAGI1 overexpressing; shMAGI1, MAGI1 
silenced. 
 
 
 







